Nivestim™ in Treatment of Malignant Diseases

NCT01627990 · clinicaltrials.gov ↗

COMPLETED

Status

386

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour
Malignant Haematological Tumour
Primary or Secondary Prophylactic Treatment

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer